Prolonged Adrenal Insufficiency After Failed Cryoablation and Osilodrostat for Cushing Syndrome in Nodular Adrenal Disease
- PMID: 40303510
- PMCID: PMC12037973
- DOI: 10.1210/jcemcr/luaf091
Prolonged Adrenal Insufficiency After Failed Cryoablation and Osilodrostat for Cushing Syndrome in Nodular Adrenal Disease
Abstract
Nodular adrenocortical disease is an entity more commonly recognized in recent years. We present a case of bilateral adrenal nodular disease in a young woman with ACTH-independent Cushing syndrome. She was treated with medical therapies at her preference to avoid adrenal insufficiency (AI) from surgery. She developed intolerance to medical therapy. Cryoablation of the right adrenal nodule was performed after adrenal vein sampling identified the right adrenal as the dominant source of cortisol. Cortisol levels were normal while on medical therapy after cryoablation but quickly became elevated after discontinuing medical therapy. The patient was then treated with osilodrostat and ultimately developed medication-induced AI that has persisted for more than 3 years. Due to the increased availability of new medications to treat Cushing syndrome, we present our experience to educate endocrinology audiences about the unexpected responses to medications. Using osilodrostat (off-label) in this patient led to prolonged primary AI after 4 months of use and now presumed permanent AI 36 months after discontinuation of treatment.
Keywords: Cushing syndrome; adrenal adenoma; adrenal insufficiency; adrenal nodule; osilodrostat.
© The Author(s) 2025. Published by Oxford University Press on behalf of the Endocrine Society.
Figures




Similar articles
-
Prolonged Adrenal Insufficiency After Osilodrostat Exposure With Eventual Recovery of Adrenal Function.JCEM Case Rep. 2024 Jun 3;2(6):luae088. doi: 10.1210/jcemcr/luae088. eCollection 2024 Jun. JCEM Case Rep. 2024. PMID: 38832004 Free PMC article.
-
A Case of Severe Cushing Syndrome due to Metastatic Adrenocortical Carcinoma Treated With Osilodrostat.AACE Clin Case Rep. 2024 Oct 23;11(1):53-57. doi: 10.1016/j.aace.2024.10.005. eCollection 2025 Jan-Feb. AACE Clin Case Rep. 2024. PMID: 39896957 Free PMC article.
-
Adrenal Cushing's Syndrome Treated With Preoperative Osilodrostat and Adrenalectomy.AACE Clin Case Rep. 2022 Oct 10;8(6):267-270. doi: 10.1016/j.aace.2022.10.001. eCollection 2022 Nov-Dec. AACE Clin Case Rep. 2022. PMID: 36447826 Free PMC article.
-
Osilodrostat: A Review of Recent Clinical Studies and Practical Recommendations for its Use in the Treatment of Cushing Disease.Endocr Pract. 2021 Sep;27(9):956-965. doi: 10.1016/j.eprac.2021.06.012. Epub 2021 Aug 10. Endocr Pract. 2021. PMID: 34389514 Review.
-
Osilodrostat Treatment for Adrenal and Ectopic Cushing Syndrome: Integration of Clinical Studies With Case Presentations.J Endocr Soc. 2025 Feb 14;9(4):bvaf027. doi: 10.1210/jendso/bvaf027. eCollection 2025 Mar 3. J Endocr Soc. 2025. PMID: 40104565 Free PMC article. Review.
References
-
- Young WF Jr., du Plessis H, Thompson GB, et al. The clinical conundrum of corticotropin-independent autonomous cortisol secretion in patients with bilateral adrenal masses. World J Surg. 2008;32(5):856‐862. - PubMed
-
- Acharya R, Dhir M, Bandi R, Yip L, Challinor S. Outcomes of adrenal venous sampling in patients with bilateral adrenal masses and ACTH-independent Cushing's syndrome. World J Surg. 2019;43(2):527‐533. - PubMed
-
- Johnson PC, Thompson SM, Adamo D, et al. Adrenal venous sampling for lateralization of cortisol hypersecretion in patients with bilateral adrenal masses. Clin Endocrinol (Oxf). 2023;98(2):177‐189. - PubMed
-
- Pivonello R, Fleseriu M, Newell-Price J, et al. Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase. Lancet Diabetes Endocrinol. 2020;8(9):748‐761. - PubMed
-
- de Cremoux P, Rosenberg D, Goussard J, et al. Expression of progesterone and estradiol receptors in normal adrenal cortex, adrenocortical tumors, and primary pigmented nodular adrenocortical disease. Endocr Relat Cancer. 2008;15(2):465‐474. - PubMed
Publication types
LinkOut - more resources
Full Text Sources